Pulse waveform characteristics predict cardiovascular events and mortality in patients undergoing coronary angiography

被引:100
|
作者
Weber, Thomas [1 ,2 ]
O'Rourke, Michael F. [3 ,4 ]
Lassnig, Elisabeth [1 ]
Porodko, Michael [1 ]
Ammer, Marcus [1 ]
Rammer, Martin [1 ]
Eber, Bernd [1 ]
机构
[1] Klinikum Wels Grieskirchen, Dept Cardiol, A-4600 Wels, Austria
[2] Paracelsus Med Univ, Salzburg, Austria
[3] Univ New S Wales, Kensington, NSW 2033, Australia
[4] St Vincents Clin, Sydney, NSW, Australia
关键词
augmentation index; blood pressure; coronary artery disease; pulse waveform analysis; wave reflections; ASCENDING AORTIC PRESSURE; LARGE ARTERY STIFFNESS; STAGE RENAL-FAILURE; AUGMENTATION INDEX; BLOOD-PRESSURE; REFLECTIONS PREDICT; DISEASE; RISK; VELOCITY; IMPACT;
D O I
10.1097/HJH.0b013e328336c8e9
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objectives Pulse waveform characteristics (Augmentation Index - AIx and pulse wave transit time) are measures of the timing and extent of arterial wave reflections. Although previous studies reported an independent association with cardiovascular morbidity, it remains to be established that waveform characteristics, derived from noninvasive pulse waveform analysis, predict cardiovascular outcomes independent of and additional to brachial blood pressure. Methods We prospectively assessed AIx, heart-rate corrected AIx, and pulse wave transit time, using radial applanation tonometry and a validated transfer function to generate the aortic pressure curve, in 520 male patients undergoing coronary angiography. Primary endpoint was a composite of all-cause mortality, myocardial infarction, stroke, cardiac, cerebrovascular, and peripheral revascularization. Results During a follow-up of 49 months, 170 patients reached the primary endpoint. On the basis of Cox proportional hazards regression models, all pressure waveform characteristics predicted the primary endpoint. A 10% increase of AIx and heart-rate corrected AIx was associated with a 20.5% (95% confidence interval 6.5-36.4, P=0.003) and 31.4% (95% confidence interval 13.2-52.6, P=0.0004) increased risk of the primary endpoint, respectively. A 10-ms increase of pulse wave transit time was associated with a 20.8% (95% confidence interval 10.8-29.6, P=0.0001) lower risk of the primary endpoint. In multiple adjusted models, AIx, heart-rate corrected AIx, and pulse wave transit time were independently associated with the combined endpoint even after adjustments for brachial blood pressure, age, extent of coronary artery disease, clinical characteristics, and medications. Conclusion The study provides evidence that pulse waveform characteristics consistently and independently predict cardiovascular events in coronary patients. J Hypertens 28: 797-805 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:797 / 805
页数:9
相关论文
共 50 条
  • [21] Comparison of Brachial Artery Wall Thickness Versus Endothelial Function to Predict Late Cardiovascular Events in Patients Undergoing Elective Coronary Angiography
    Suessenbacher, Alois
    Doerler, Jakob
    Wunder, Johannes
    Hohenwarter, Fabian
    Alber, Hannes F.
    Pachinger, Otmar
    Frick, Matthias
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (05): : 671 - 675
  • [22] Association between high plasma levels of legumain and cardiovascular events in patients undergoing coronary angiography
    Momiyama, Yukihiko
    Kishimoto, Yoshimi
    Saita, Emi
    Ohmori, Reiko
    Kondo, Kazuo
    HEART AND VESSELS, 2024, 39 (10) : 909 - 915
  • [23] Impact of glomerular filtration rate estimation on cardiovascular events in elderly patients undergoing coronary angiography
    Aker, Amir
    Eitan, Amnon
    Saliba, Walid
    Jaffe, Ronen
    Zafrir, Barak
    CORONARY ARTERY DISEASE, 2022, 33 (03) : 161 - 168
  • [24] The impact of glomerular filtration rate estimation on cardiovascular events in elderly patients undergoing coronary angiography
    Aker, A.
    Eitan, A.
    Saliba, W.
    Jaffe, R.
    Zafrir, B.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2908 - 2908
  • [25] Effect of kidney disease on all-cause and cardiovascular mortality in patients undergoing coronary angiography
    Li, Qiang
    Shi, Shanshan
    Lu, Xiaozhao
    Huang, Haozhang
    Deng, Jingru
    Chen, Weihua
    Lai, Wenguang
    Liang, Guoxiao
    Wang, Yani
    Gallagher, Martin
    Wang, Amanda Y.
    Chen, Jiyan
    Liu, Jin
    Liu, Yong
    RENAL FAILURE, 2023, 45 (01)
  • [26] IMPAIRED GLUCOSE TOLERANCE SIGNIFICANTLY INCREASES THE RISK FOR CARDIOVASCULAR EVENTS IN PATIENTS UNDERGOING ELECTIVE CORONARY ANGIOGRAPHY
    Sourij, H.
    Saely, C. H.
    Aczel, S.
    Zweiker, R.
    Langer, P.
    Kettler-Schmut, E.
    Marte, T.
    Hoefle, G.
    Benzer, W.
    Wascher, T. C.
    Drexel, H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 8 - 8
  • [27] Galectin-1 is associated with the severity of coronary artery disease and adverse cardiovascular events in patients undergoing coronary angiography
    Chou, Ruey-Hsing
    Huang, Shao-Sung
    Kuo, Chin-Sung
    Wang, Shen-Chih
    Tsai, Yi-Lin
    Lu, Ya-Wen
    Chang, Chun-Chin
    Huang, Po-Hsun
    Lin, Shing-Jong
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [28] Galectin-1 is associated with the severity of coronary artery disease and adverse cardiovascular events in patients undergoing coronary angiography
    Ruey-Hsing Chou
    Shao-Sung Huang
    Chin-Sung Kuo
    Shen-Chih Wang
    Yi-Lin Tsai
    Ya-Wen Lu
    Chun-Chin Chang
    Po-Hsun Huang
    Shing-Jong Lin
    Scientific Reports, 10
  • [29] Impaired glucose tolerance significantly increases the risk for cardiovascular events in patients undergoing elective coronary angiography
    Sourij, H.
    Saely, C. H.
    Aczel, S.
    Zweiker, R.
    Langer, P.
    Passler, P.
    Marte, T.
    Hoefle, G.
    Benzer, W.
    Wascher, T. C.
    Drexel, H.
    DIABETOLOGIA, 2008, 51 : S547 - S547
  • [30] Circulating galectin 1 is associated with severity of coronary artery disease and adverse cardiovascular events in patients undergoing coronary angiography
    Chou, R. -H.
    Lu, Y. -W.
    Huang, P. -H.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3392 - 3392